A new research paper was published in Volume 17, Issue 10 of Aging-US on October 3, 2025, titled “The role of phenylalanine and tyrosine in longevity: a cohort and Mendelian randomization study.”
Aging-US Authors
“These findings suggest a physiological interaction between exercise and L-BAIBA supplementation to improve soleus muscle and bone properties and reduce bone marrow adiposity.” BUFFALO, NY
A new editorial was published in Aging-US on October 13, 2025, titled “Longevity clinics: between promise and peril.”
Girish Harinath from AgelessRx joins host Dr. Evgeniy Galimov to discuss a research paper he co-authored in Volume 17, Issue 4 of Aging-US, titled “Influence of rapamycin on safety and healthspan metrics after one year: PEARL trial results.”
Aging-US is proud to sponsor a Poster Prize recognizing outstanding scientific research presented at the 10th Annual ICSA Conference & 2nd Phaedon SenoTherapeutics Summit.
Aging (Aging-US) is proud to support a milestone event for the global senescence and aging research community.
Dr. Stefanie Morgan joins Dr. Robert Dudley from AgelessRx to discuss a research paper she co-authored in Aging, entitled “Influence of rapamycin on safety and healthspan metrics after one year: PEARL trial results.”
The Longevity & Aging Series has been honored with the Silver Award for “Excellence in Video/Film” at the inaugural EPIC Awards celebration on May 29, 2025, during the Society for Scholarly Publishing (SSP) 47th Annual Meeting in Baltimore, Maryland.
A new research paper was published in Aging (Aging-US) Volume 17, Issue 4, on April 4, 2025, titled “Influence of rapamycin on safety and healthspan metrics after one year: PEARL trial results.”
Dr. Stephen Vatner from Rutgers New Jersey Medical School, joins host Dr. Evgeniy Galimov to discuss a research perspective he co-authored in Volume 16, Issue 22 of Aging (Aging-US), titled “Brown adipose tissue enhances exercise performance and healthful longevity.”